Clinical Trial Update: Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant chemotherapy plus Cadonilimab for locally advanced cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Female, Age ≥ 18 Years Old, No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy | Phase 2 | Status: RECRUITING